Rigel Pharmaceuticals, Inc.

Direct answer

Rigel Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker RIGL.

Rigel Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering and developing small molecule therapies. The firm's focus areas include hematologic disorders, oncology, and rare immune system conditions. Its commercialized product, Tavalisse (fostamatinib), is an oral spleen tyrosine kinase inhibitor approved for the treatment of chronic immune thrombocytopenia in adult patients. Rigel's robust...

Can you invest in Rigel Pharmaceuticals, Inc.?

Yes. Rigel Pharmaceuticals, Inc. trades publicly on NASDAQ as RIGL.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Rigel Pharmaceuticals, Inc.

Detailed equity research is provided by MarketSnap.